AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 1 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $19,718,000 | – | 573,434 | – | 8.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,854,631 | $144,911,000 | 10.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,267,382 | $187,081,000 | 6.82% |
| Consonance Capital Management LP | 1,493,560 | $44,583,000 | 6.12% |
| Healthcare Value Capital, LLC | 200,000 | $5,970,000 | 5.76% |
| Tiger Legatus Capital Management, LLC | 500,000 | $14,925,000 | 5.29% |
| Tamarack Capital Management, LLC | 650,000 | $19,403,000 | 4.30% |
| KING INVESTMENT ADVISORS INC/TX | 282,675 | $8,438,000 | 3.84% |
| TIG Advisors, LLC | 2,799,913 | $83,577,000 | 3.21% |
| Artal Group S.A. | 2,275,000 | $67,909,000 | 2.50% |
| JET CAPITAL INVESTORS L P | 2,100,000 | $62,685,000 | 2.31% |